Literature DB >> 23801389

Accuracy of tumour size assessment in the preoperative staging of breast cancer: comparison of digital mammography, tomosynthesis, ultrasound and MRI.

Andrea Luparia1, Giovanna Mariscotti, Manuela Durando, Stefano Ciatto, Davide Bosco, Pier Paolo Campanino, Isabella Castellano, Anna Sapino, Giovanni Gandini.   

Abstract

PURPOSE: Accurate measurement of breast tumour size is fundamental for treatment planning. We compared the accuracy of digital mammography (DM), digital breast tomosynthesis (DBT), ultrasound (US) and magnetic resonance imaging (MRI) for the preoperative evaluation of breast cancer size.
MATERIALS AND METHODS: We retrospectively reviewed 149 breast cancers in 110 patients who underwent DM, DBT, US and MRI between January 2010 and December 2011, before definitive surgery. The lesions were measured by two radiologists, without knowledge of the final histological examination, considered the gold standard. For each imaging modality, the maximum tumour size was measured to the nearest millimetre; the measurements were considered concordant if they were within ± 5 mm. Pearson's correlation coefficient was calculated for each imaging modality.
RESULTS: The median pathological tumour size was 22.3 mm. MRI and DBT had a level of concordance with pathology of 70% and 66%, respectively, which was higher than that of DM (54%). DBT and MRI measurements had a better correlation with pathological tumour size (R:0.89 and R:0.92, respectively) compared to DM (R:0.83) and US (R:0.77).
CONCLUSIONS: DBT and MRI are superior to DM and US in the preoperative assessment of breast tumour size. DBT seems to improve the accuracy of DM, although MRI remains the most accurate imaging modality for breast cancer extension.

Entities:  

Mesh:

Year:  2013        PMID: 23801389     DOI: 10.1007/s11547-013-0941-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  23 in total

1.  Indications for breast magnetic resonance imaging. Consensus document "Attualità in senologia", Florence 2007.

Authors:  F Sardanelli; G M Giuseppetti; G Canavese; L Cataliotti; S Corcione; E Cossu; M Federico; L Marotti; L Martincich; P Panizza; F Podo; M Rosselli Del Turco; C Zuiani; C Alfano; M Bazzocchi; P Belli; S Bianchi; A Cilotti; M Calabrese; L Carbonaro; L Cortesi; C Di Maggio; A Del Maschio; A Esseridou; A Fausto; M Gennaro; R Girometti; R Ienzi; A Luini; S Manoukian; S Morassutt; D Morrone; J Nori; A Orlacchio; F Pane; P Panzarola; R Ponzone; G Simonetti; P Torricelli; G Valeri
Journal:  Radiol Med       Date:  2008-10-16       Impact factor: 3.469

2.  [Accuracy of preoperative establishment of invasive breast carcinoma size using ultrasound and mammography].

Authors:  P Vrtelová; O Coufal; V Fait; V Chrenko
Journal:  Rozhl Chir       Date:  2010-10

3.  Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics.

Authors:  Peter A Fasching; Katharina Heusinger; Christian R Loehberg; Evelyn Wenkel; Michael P Lux; Michael Schrauder; Thomas Koscheck; Werner Bautz; Rüdiger Schulz-Wendtland; Matthias W Beckmann; Mayada R Bani
Journal:  Eur J Radiol       Date:  2006-10-09       Impact factor: 3.528

4.  Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer.

Authors:  W T Yang; W W Lam; H Cheung; M Suen; W W King; C Metreweli
Journal:  J Ultrasound Med       Date:  1997-12       Impact factor: 2.153

5.  Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography.

Authors:  P L Davis; M J Staiger; K B Harris; M A Ganott; J Klementaviciene; K S McCarty; H Tobon
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes.

Authors:  Francesco Sardanelli
Journal:  Breast       Date:  2010-02       Impact factor: 4.380

7.  Prediction of breast tumor size by mammography and sonography--A breast screen experience.

Authors:  L J Dummin; M Cox; L Plant
Journal:  Breast       Date:  2006-07-18       Impact factor: 4.380

8.  Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements.

Authors:  Jill K Onesti; Barry E Mangus; Stephen D Helmer; Jacqueline S Osland
Journal:  Am J Surg       Date:  2008-12       Impact factor: 2.565

9.  Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer.

Authors:  Takayoshi Uematsu; Sachiko Yuen; Masako Kasami; Yoshihiro Uchida
Journal:  Breast Cancer Res Treat       Date:  2008-01-12       Impact factor: 4.872

Review 10.  MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature.

Authors:  Ritse M Mann; Yvonne L Hoogeveen; Johan G Blickman; Carla Boetes
Journal:  Breast Cancer Res Treat       Date:  2007-02-15       Impact factor: 4.872

View more
  32 in total

1.  Digital Breast Tomosynthesis: State of the Art.

Authors:  Srinivasan Vedantham; Andrew Karellas; Gopal R Vijayaraghavan; Daniel B Kopans
Journal:  Radiology       Date:  2015-12       Impact factor: 11.105

Review 2.  Preoperative imaging for breast conservation surgery-do we need more than conventional imaging for local disease assessment?

Authors:  Eugene Ong
Journal:  Gland Surg       Date:  2018-12

3.  MRI in the differential diagnosis of primary architectural distortion detected by mammography.

Authors:  Lifang Si; Renyou Zhai; Xiaojuan Liu; Kaiyan Yang; Li Wang; Tao Jiang
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

4.  Three-dimensional segmentation of breast masses from digital breast tomosynthesis images.

Authors:  Stefanie T L Pöhlmann; Yit Y Lim; Elaine Harkness; Susan Pritchard; Christopher J Taylor; Susan M Astley
Journal:  J Med Imaging (Bellingham)       Date:  2017-09-19

5.  Imaging features and conspicuity of invasive lobular carcinomas on digital breast tomosynthesis.

Authors:  Foucauld Chamming's; Ellen Kao; Ann Aldis; Romuald Ferré; Atilla Omeroglu; Caroline Reinhold; Benoit Mesurolle
Journal:  Br J Radiol       Date:  2017-04-03       Impact factor: 3.039

6.  Calibration and optimization of 3D digital breast tomosynthesis guided near infrared spectral tomography.

Authors:  Kelly E Michaelsen; Venkataramanan Krishnaswamy; Linxi Shi; Srinivasan Vedantham; Steven P Poplack; Andrew Karellas; Brian W Pogue; Keith D Paulsen
Journal:  Biomed Opt Express       Date:  2015-11-19       Impact factor: 3.732

7.  Prediction of tumor size in patients with invasive ductal carcinoma using FT-IR spectroscopy combined with chemometrics: a preliminary study.

Authors:  Zhimin Zhu; Chen Chen; Cheng Chen; Ziwei Yan; Fangfang Chen; Bo Yang; Huiting Zhang; Huijie Han; Xiaoyi Lv
Journal:  Anal Bioanal Chem       Date:  2021-03-22       Impact factor: 4.142

8.  Intraoperative micro-computed tomography (micro-CT): a novel method for determination of primary tumour dimensions in breast cancer specimens.

Authors:  Rong Tang; Mansi Saksena; Suzanne B Coopey; Leopoldo Fernandez; Julliette M Buckley; Lan Lei; Owen Aftreth; Frederick Koerner; James Michaelson; Elizabeth Rafferty; Elena Brachtel; Barbara L Smith
Journal:  Br J Radiol       Date:  2015-11-16       Impact factor: 3.039

9.  Automated breast volume scanner (ABVS) in assessing breast cancer size: A comparison with conventional ultrasound and magnetic resonance imaging.

Authors:  Rossano Girometti; Martina Zanotel; Viviana Londero; Anna Linda; Michele Lorenzon; Chiara Zuiani
Journal:  Eur Radiol       Date:  2017-10-10       Impact factor: 5.315

10.  Contrast enhanced digital mammography versus magnetic resonance imaging for accurate measurement of the size of breast cancer.

Authors:  Inyoung Youn; SeonHyeong Choi; Yoon Jung Choi; Ju Hee Moon; Hee Jin Park; Soo-Youn Ham; Chan Heun Park; Eun Young Kim; Shin Ho Kook
Journal:  Br J Radiol       Date:  2019-04-24       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.